Pharma Industry News Biogen and Eisai’s Leqembi study shows nearly 83% of early Alzheimer’s patients remained stable or improved 1 hour agoAdd Commentby David Miller946 Views The real-world findings support the long-term benefits of continuous treatment Source: PMLiVE